About: Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $43.86 (+3.32%)
VCYTNASDAQVeracyte Inc
Veracyte Inc share price
VCYT price activity
Last Price
$43.860
Change (24hr)
1.41 USD (3.32%)
Volume
1.45M
Volume (4w avg)
-
Open
$42.79
Day Range
$42.39 - $44.20
Previous Close
$42.45
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
VCYT price performance
Delayed
09 Sep, 8:00 pm GMT+0
VCYT Market Signals